{"pmid":32495493,"title":"COVID-19: a lever for the recognition of obesity as a disease? The French experience.","text":["COVID-19: a lever for the recognition of obesity as a disease? The French experience.","Despite repeated efforts by the international scientific community, academic societies and the combined actions of patient associations, public authorities have difficulties in admitting that obesity is not just a risk factor but a disease. Could our current experience with the COVID-19 pandemic be a lever to advance the cause of people with obesity? In this crisis, it seems pertinent to report on the French experience with the actions of stakeholders that were able to challenge the status quo in this field.","Obesity (Silver Spring)","Clement, Karine","Coupaye, Muriel","Laville, Martine","Oppert, Jean-Michel","Ziegler, Olivier","32495493"],"abstract":["Despite repeated efforts by the international scientific community, academic societies and the combined actions of patient associations, public authorities have difficulties in admitting that obesity is not just a risk factor but a disease. Could our current experience with the COVID-19 pandemic be a lever to advance the cause of people with obesity? In this crisis, it seems pertinent to report on the French experience with the actions of stakeholders that were able to challenge the status quo in this field."],"journal":"Obesity (Silver Spring)","authors":["Clement, Karine","Coupaye, Muriel","Laville, Martine","Oppert, Jean-Michel","Ziegler, Olivier"],"date":"2020-06-05T11:00:00Z","year":2020,"_id":"32495493","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/oby.22924","keywords":["covid-19","france","health authorities","obesity"],"locations":["French","French"],"countries":["France"],"countries_codes":["FRA|France"],"weight":0,"_version_":1668712823979507713,"score":9.490897,"similar":[{"pmid":32438328,"title":"Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.","text":["Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.","BACKGROUND AND AIMS: COVID-19 is an emerging pandemic due to droplet infection of 2019-novel coronavirus (2019-nCoV). Due to its rapid transmission and high case-fatality rate, recognition of its risk and prognostic factor is important. Obesity has been associated with impaired immune system, increasing the susceptibility for 2019-nCoV infection. We aimed to study the impact of obesity to the prognosis and disease severity of COVID-19. METHODS: A systematic search and handsearching was conducted in four databases: Cochrane, MEDLINE, EMBASE, and PubMed. The identified articles were screened using the chosen eligibility criteria. We obtained three retrospective cohort studies (Wu J et al., Lighter J et al., and Simonnet A et al.) to be critically appraised using Newcastle Ottawa Scale. RESULTS: The findings of all included studies were consistent in stating the contribution of obesity as a risk factor to increase the requirement for advanced medical care. Study with the highest quality, Simonnet A et al., reported an increase need of invasive mechanical ventilation in COVID-19 patients with body mass index higher than 35 kg/m(2), OR: 7.36 (1.63-33.14; p = 0.021). This is associated with a higher mortality rate in obese population infected with COVID-19. CONCLUSION: Obesity is an independent risk and prognostic factor for the disease severity and the requirement of advanced medical care in COVID-19. This systematic review highlights a particularly vulnerable group - obese, and emphasises on the importance of treatment aggression and disease prevention in this population group.","Diabetes Metab Syndr","Tamara, Alice","Tahapary, Dicky L","32438328"],"abstract":["BACKGROUND AND AIMS: COVID-19 is an emerging pandemic due to droplet infection of 2019-novel coronavirus (2019-nCoV). Due to its rapid transmission and high case-fatality rate, recognition of its risk and prognostic factor is important. Obesity has been associated with impaired immune system, increasing the susceptibility for 2019-nCoV infection. We aimed to study the impact of obesity to the prognosis and disease severity of COVID-19. METHODS: A systematic search and handsearching was conducted in four databases: Cochrane, MEDLINE, EMBASE, and PubMed. The identified articles were screened using the chosen eligibility criteria. We obtained three retrospective cohort studies (Wu J et al., Lighter J et al., and Simonnet A et al.) to be critically appraised using Newcastle Ottawa Scale. RESULTS: The findings of all included studies were consistent in stating the contribution of obesity as a risk factor to increase the requirement for advanced medical care. Study with the highest quality, Simonnet A et al., reported an increase need of invasive mechanical ventilation in COVID-19 patients with body mass index higher than 35 kg/m(2), OR: 7.36 (1.63-33.14; p = 0.021). This is associated with a higher mortality rate in obese population infected with COVID-19. CONCLUSION: Obesity is an independent risk and prognostic factor for the disease severity and the requirement of advanced medical care in COVID-19. This systematic review highlights a particularly vulnerable group - obese, and emphasises on the importance of treatment aggression and disease prevention in this population group."],"journal":"Diabetes Metab Syndr","authors":["Tamara, Alice","Tahapary, Dicky L"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32438328","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.dsx.2020.05.020","keywords":["covid-19","obesity","predictor","prognosis"],"locations":["obese"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667521393560911872,"score":134.98705},{"pmid":32271993,"title":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","text":["High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","OBJECTIVE: The Covid-19 pandemic is rapidly spreading worldwide, notably in Europe and North America, where obesity is highly prevalent. The relation between obesity and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has not been fully documented. METHODS: In this retrospective cohort study we analyzed the relationship between clinical characteristics, including body mass index (BMI), and the requirement for invasive mechanical ventilation (IMV) in 124 consecutive patients admitted in intensive care for SARS-CoV-2, in a single French center. RESULTS: Obesity (BMI >30 kg/m2) and severe obesity (BMI >35 kg/m2) were present in 47.6% and 28.2% of cases, respectively. Overall, 85 patients (68.6%) required IMV. The proportion of patients who required IMV increased with BMI categories (p<0.01, Chi square test for trend), and it was greatest in patients with BMI >35 kg/m2 (85.7%). In multivariate logistic regression, the need for IMV was significantly associated with male sex (p<0.05) and BMI (p<0.05), independent of age, diabetes, and hypertension. The odds ratio for IMV in patients with BMI >35 kg/m2 vs patients with BMI <25 kg/m2 was 7.36 (1.63-33.14; p=0.02) CONCLUSION: The present study showed a high frequency of obesity among patients admitted in intensive care for SARS-CoV-2. Disease severity increased with BMI. Obesity is a risk factor for SARS-CoV-2 severity requiring increased attention to preventive measures in susceptible individuals.","Obesity (Silver Spring)","Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce","32271993"],"abstract":["OBJECTIVE: The Covid-19 pandemic is rapidly spreading worldwide, notably in Europe and North America, where obesity is highly prevalent. The relation between obesity and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has not been fully documented. METHODS: In this retrospective cohort study we analyzed the relationship between clinical characteristics, including body mass index (BMI), and the requirement for invasive mechanical ventilation (IMV) in 124 consecutive patients admitted in intensive care for SARS-CoV-2, in a single French center. RESULTS: Obesity (BMI >30 kg/m2) and severe obesity (BMI >35 kg/m2) were present in 47.6% and 28.2% of cases, respectively. Overall, 85 patients (68.6%) required IMV. The proportion of patients who required IMV increased with BMI categories (p<0.01, Chi square test for trend), and it was greatest in patients with BMI >35 kg/m2 (85.7%). In multivariate logistic regression, the need for IMV was significantly associated with male sex (p<0.05) and BMI (p<0.05), independent of age, diabetes, and hypertension. The odds ratio for IMV in patients with BMI >35 kg/m2 vs patients with BMI <25 kg/m2 was 7.36 (1.63-33.14; p=0.02) CONCLUSION: The present study showed a high frequency of obesity among patients admitted in intensive care for SARS-CoV-2. Disease severity increased with BMI. Obesity is a risk factor for SARS-CoV-2 severity requiring increased attention to preventive measures in susceptible individuals."],"journal":"Obesity (Silver Spring)","authors":["Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271993","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/oby.22831","keywords":["covid-19","sras-cov-2","body mass index","intensive care","mechanical ventilation","obesity"],"locations":["French"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1666138491829878786,"score":134.10468},{"pmid":32463545,"title":"Obesity and COVID-19: an Italian snapshot.","text":["Obesity and COVID-19: an Italian snapshot.","OBJECTIVE: The clinical manifestations of COVID-19 run from asymptomatic disease to severe acute respiratory syndrome. Older age and comorbidities are associated to more severe disease. A role of obesity is suspected. METHODS: We enrolled patients hospitalized in the medical COVID-19 ward with SARS-CoV-2 related pneumonia. Primary outcome of the study was to assess the relationship between the severity of COVID-19 and obesity classes according to BMI. RESULTS: 92 patients (61.9% males; age 70.5+/-13.3 years) were enrolled. Patients with overweight and obesity were younger than normal-weight patients (68.0+/-12.6 and 67.0+/-12.6 years vs. 76.1+/-13.0 years, p<0.01). A higher need for assisted ventilation beyond pure oxygen support (Invasive Mechanical Ventilation or Non-Invasive Ventilation) and a higher admission to intensive or semi-intensive care units was observed in patients with overweight and obesity (p<0.01 and p < 0.05, respectively) even after adjusting for sex, age and comorbidities (p<0.05 and p<0.001, respectively), or when patients with dementia or advanced cancer were removed from the analysis (p<0.05). CONCLUSION: Patients with overweight and obesity admitted in a medical ward for SARS-CoV-2 related pneumonia, despite their younger age, required more frequently assisted ventilation and access to intensive or semi-intensive care units than normal weight patients.","Obesity (Silver Spring)","Busetto, Luca","Bettini, Silvia","Fabris, Roberto","Serra, Roberto","Dal Pra', Chiara","Maffei, Pietro","Rossato, Marco","Fioretto, Paola","Vettor, Roberto","32463545"],"abstract":["OBJECTIVE: The clinical manifestations of COVID-19 run from asymptomatic disease to severe acute respiratory syndrome. Older age and comorbidities are associated to more severe disease. A role of obesity is suspected. METHODS: We enrolled patients hospitalized in the medical COVID-19 ward with SARS-CoV-2 related pneumonia. Primary outcome of the study was to assess the relationship between the severity of COVID-19 and obesity classes according to BMI. RESULTS: 92 patients (61.9% males; age 70.5+/-13.3 years) were enrolled. Patients with overweight and obesity were younger than normal-weight patients (68.0+/-12.6 and 67.0+/-12.6 years vs. 76.1+/-13.0 years, p<0.01). A higher need for assisted ventilation beyond pure oxygen support (Invasive Mechanical Ventilation or Non-Invasive Ventilation) and a higher admission to intensive or semi-intensive care units was observed in patients with overweight and obesity (p<0.01 and p < 0.05, respectively) even after adjusting for sex, age and comorbidities (p<0.05 and p<0.001, respectively), or when patients with dementia or advanced cancer were removed from the analysis (p<0.05). CONCLUSION: Patients with overweight and obesity admitted in a medical ward for SARS-CoV-2 related pneumonia, despite their younger age, required more frequently assisted ventilation and access to intensive or semi-intensive care units than normal weight patients."],"journal":"Obesity (Silver Spring)","authors":["Busetto, Luca","Bettini, Silvia","Fabris, Roberto","Serra, Roberto","Dal Pra', Chiara","Maffei, Pietro","Rossato, Marco","Fioretto, Paola","Vettor, Roberto"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463545","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/oby.22918","keywords":["covid-19","sars-cov-2","obesity"],"locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668079521204535298,"score":133.9986},{"pmid":32445512,"title":"Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","text":["Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.","OBJECTIVE: COVID-19 continues to spread and younger patients are also being critically affected. This study analyzed obesity as an independent risk factor for mortality in hospitalized patients younger than fifty. METHODS: We retrospectively analyzed data of COVID-19 patients hospitalized to a large academic hospital system in New York City between March 1st and May 17th, 2020. Data included demographics, comorbidities, BMI and smoking status. Obesity groups included: BMI 30-40 kg/m(2) and BMI >/= 40 kg/m(2) . Multivariable logistic regression models identified variables independently associated with mortality in patients younger and older than 50. RESULTS: Overall, 3,406 patients were included. 572 (17.0%) of the patients were younger than 50. In the younger age group, 60 (10.5%) patients died. In the older age group, 1,076 (38.0%) patients died. For the younger population, BMI above 40 kg/m(2) was independently associated with mortality (aOR 5.1, 95% CI 2.3-11.1). For the older population, BMI above 40 kg/m2 was also independently associated with mortality to a lesser extent (aOR 1.6, 95% CI 1.2 - 2.3). CONCLUSION: Our study demonstrates that hospitalized patients younger than 50 with morbid obesity are more likely to die from COVID-19. This is particularly relevant in the western world where obesity rates are high.","Obesity (Silver Spring)","Klang, Eyal","Kassim, Gassan","Soffer, Shelly","Freeman, Robert","Levin, Matthew A","Reich, David L","32445512"],"abstract":["OBJECTIVE: COVID-19 continues to spread and younger patients are also being critically affected. This study analyzed obesity as an independent risk factor for mortality in hospitalized patients younger than fifty. METHODS: We retrospectively analyzed data of COVID-19 patients hospitalized to a large academic hospital system in New York City between March 1st and May 17th, 2020. Data included demographics, comorbidities, BMI and smoking status. Obesity groups included: BMI 30-40 kg/m(2) and BMI >/= 40 kg/m(2) . Multivariable logistic regression models identified variables independently associated with mortality in patients younger and older than 50. RESULTS: Overall, 3,406 patients were included. 572 (17.0%) of the patients were younger than 50. In the younger age group, 60 (10.5%) patients died. In the older age group, 1,076 (38.0%) patients died. For the younger population, BMI above 40 kg/m(2) was independently associated with mortality (aOR 5.1, 95% CI 2.3-11.1). For the older population, BMI above 40 kg/m2 was also independently associated with mortality to a lesser extent (aOR 1.6, 95% CI 1.2 - 2.3). CONCLUSION: Our study demonstrates that hospitalized patients younger than 50 with morbid obesity are more likely to die from COVID-19. This is particularly relevant in the western world where obesity rates are high."],"journal":"Obesity (Silver Spring)","authors":["Klang, Eyal","Kassim, Gassan","Soffer, Shelly","Freeman, Robert","Levin, Matthew A","Reich, David L"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445512","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/oby.22913","keywords":["covid-19","sars-cov-2","hospitalization","mortality","obesity"],"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1667600475964309504,"score":127.55356},{"pmid":32352637,"title":"Association of Obesity with Disease Severity among Patients with COVID-19.","text":["Association of Obesity with Disease Severity among Patients with COVID-19.","OBJECTIVE: To explore the potential association of obesity and other chronic diseases with severe outcomes, such as intensive care unit (ICU) admission and invasive mechanical ventilation (IMV), in patients hospitalized with COVID-19. METHODS: Retrospective cohort of 103 patients hospitalized with COVID-19. Demographic data, past medical history and hospital course were collected and analyzed. A multivariate logistic regression analysis was implemented to examine associations. RESULTS: From February 17th to April 5th, 103 consecutive patients were hospitalized with COVID-19. Among them, 41 patients (39.8%) were admitted to the ICU and 29 (70.7%) required (IMV). The prevalence of obesity was 47.5% (49/103). In a multivariate analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission (aOR 5.39; 95% CI:1.13-25.64). Moreover, patients who required IMV, were more likely to have had heart disease (aOR 3.41; 95% CI:1.05-11.06), obesity (BMI=30-34.9 kg/m2) (aOR 6.85; 95% CI: 1.05-44.82) or severe obesity (BMI>/=35 kg/m2) (aOR 9.99; 95% CI:1.39-71.69). CONCLUSION: In our analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission, while history of heart disease and obesity (BMI >/=30 kg/m2) were independently associated with the use of IMV. Increased vigilance and aggressive treatment of patients with obesity and COVID-19 are warranted.","Obesity (Silver Spring)","Kalligeros, Markos","Shehadeh, Fadi","Mylona, Evangelia K","Benitez, Gregorio","Beckwith, Curt G","Chan, Philip A","Mylonakis, Eleftherios","32352637"],"abstract":["OBJECTIVE: To explore the potential association of obesity and other chronic diseases with severe outcomes, such as intensive care unit (ICU) admission and invasive mechanical ventilation (IMV), in patients hospitalized with COVID-19. METHODS: Retrospective cohort of 103 patients hospitalized with COVID-19. Demographic data, past medical history and hospital course were collected and analyzed. A multivariate logistic regression analysis was implemented to examine associations. RESULTS: From February 17th to April 5th, 103 consecutive patients were hospitalized with COVID-19. Among them, 41 patients (39.8%) were admitted to the ICU and 29 (70.7%) required (IMV). The prevalence of obesity was 47.5% (49/103). In a multivariate analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission (aOR 5.39; 95% CI:1.13-25.64). Moreover, patients who required IMV, were more likely to have had heart disease (aOR 3.41; 95% CI:1.05-11.06), obesity (BMI=30-34.9 kg/m2) (aOR 6.85; 95% CI: 1.05-44.82) or severe obesity (BMI>/=35 kg/m2) (aOR 9.99; 95% CI:1.39-71.69). CONCLUSION: In our analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission, while history of heart disease and obesity (BMI >/=30 kg/m2) were independently associated with the use of IMV. Increased vigilance and aggressive treatment of patients with obesity and COVID-19 are warranted."],"journal":"Obesity (Silver Spring)","authors":["Kalligeros, Markos","Shehadeh, Fadi","Mylona, Evangelia K","Benitez, Gregorio","Beckwith, Curt G","Chan, Philip A","Mylonakis, Eleftherios"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352637","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/oby.22859","keywords":["covid-19","icu","sars-cov-2","hospitalization","intubation","obesity"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495752601600,"score":125.54343}]}